Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Inspire Medical Systems, Inc. (INSP) Profit Margins

Over the twelve months to 2026-06-30, Inspire Medical Systems, Inc. (INSP) had gross margin 86.1%, operating margin 6.0%, net margin 15.0%, free cash flow margin 13.0%, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

INSPInspire Medical Systems, Inc.Follow INSP — free
Medical Devices · Healthcare
—
Price chart with a free account
Market cap
2.1B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
2 Nov, in 9 days
LineFY2019
Dec 19
FY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Gross margin83.4%84.7%85.7%83.8%84.5%84.7%85.4%86.1%
Operating margin-42.5%-48.7%-17.1%-11.7%-6.4%4.5%5.6%6.0%
Net margin-40.5%-49.6%-18.0%-11.0%-3.4%6.7%15.9%15.0%
FCF margin-43.4%-48.1%-10.6%0.6%0.2%11.4%8.6%13.0%

USD millions · SEC XBRL

Inspire Medical Systems, Inc. — questions

What is Inspire Medical Systems, Inc.'s gross margin?
86.1% over the twelve months to 2026-06-30.
What is Inspire Medical Systems, Inc.'s operating margin?
6.0% over the twelve months to 2026-06-30.
What is Inspire Medical Systems, Inc.'s net profit margin?
15.0% over the twelve months to 2026-06-30.

Every figure on this page comes from Inspire Medical Systems, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.